GlassScriptPhysician profile
Candice N Fraser
NPI 1356784961
$1,863.78
in general payments reported to CMS, 2019-2025
16 companies · $528 in 2025
The $528 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2023: $425 · 2024: $353 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $557.77 | 2019 | |
| Astellas Pharma US INC | $410.30 | 2023-2025 | Veozah |
| Viiv Healthcare Company | $153.01 | 2025 | Apretude |
| Myriad Women'S Health, INC. | $130.89 | 2023 | Myrisk |
| Astrazeneca Pharmaceuticals LP | $122.09 | 2023 | Saphnelo |
| Hologic Sales and Service, LLC | $99.50 | 2023-2025 | Affirm Prone Biopsy System, Aptima |
| Novo Nordisk INC | $70.94 | 2023-2024 | Wegovy |
| Abbvie INC. | $69.79 | 2024 | |
| Exeltis, USA INC. | $67.54 | 2025 | Slynd |
| Lilly USA, LLC | $49.44 | 2025 | Zepbound, Mounjaro |
| Sumitomo Pharma America, INC. | $29.46 | 2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $24.02 | 2025 | |
| Shield Therapeutics INC | $22.59 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $21.90 | 2024 | Arcalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $19.22 | 2025 | Entyvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $15.32 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Fraser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.